Page 28 - Demo

%u042f%u043d%u0443%u0448%u043a%u043e %u041c.%u0413., %u0428%u0430%u043c%u0430%u043d%u0438%u043d%u0430 %u041c.%u0412.28 %u2116 4/2024 %u0421%u043e%u0432%u0440%u0435%u043c%u0435%u043d%u043d%u0430%u044f %u0442%u0435%u0440%u0430 %u043f%u0438%u044f %u043f%u0441%u0438%u0445%u0438%u0447%u0435%u0441%u043a%u0438%u0445 %u0440%u0430 %u0441%u0441%u0442%u0440%u043e%u0439%u0441%u0442%u0432 www.psypharma.ru36. Chen M.H., Hsu J.W., Huang K.L., Tsai S.J., Su T.P., Li C.T., Lin W.C., Tu P.C., Bai Y.M. Role of obesity in systemic low-grade inflammation and cognitive function in patients with bipolar I disorder or major depressive disorder // CNS Spectr. %u2013 2021. %u2013 Vol. 26, no. 5. %u2013 P%u0440. 521%u2013527. %u2013 https://doi.org/10.1017/S109285292000153436. Chen M.H., Hsu J.W., Huang K.L., Tsai S.J., Su T.P., Li C.T., Lin W.C., Tu P.C., Bai Y.M. Role of obesity in systemic low-grade inflammation and cognitive function in patients with bipolar I disorder or major depressive disorder // CNS Spectr. %u2013 2021. %u2013 Vol. 26, no. 5. %u2013 P%u0440. 521%u2013527. %u2013 https://doi.org/10.1017/S109285292000153437. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline // JAMA. %u2013 2004. %u2013 Vol. 292, no. 18. %u2013 P%u0440. 2237%u20132242. %u2013 https://doi.org/10.1001/jama.292.18.223737. Yaffe K., Kanaya A., Lindquist K., Simonsick E.M., Harris T., Shorr R.I., Tylavsky F.A., Newman A.B. The metabolic syndrome, inflammation, and risk of cognitive decline // JAMA. %u2013 2004. %u2013 Vol. 292, no. 18. %u2013 P%u0440. 2237%u20132242. %u2013 https://doi.org/10.1001/jama.292.18.223738. Grassi-Oliveira R., Bauer M.E., Pezzi J.C., Teixeira A.L., Brietzke E. Interleukin-6 and verbal memory in recurrent major depressive disorder // Neuro Endocrinol Lett. %u2013 2011. %u2013 Vol. 32, no. 4. %u2013 P%u0440. 540%u2013544.38. Grassi-Oliveira R., Bauer M.E., Pezzi J.C., Teixeira A.L., Brietzke E. Interleukin-6 and verbal memory in recurrent major depressive disorder // Neuro Endocrinol Lett. %u2013 2011. %u2013 Vol. 32, no. 4. %u2013 P%u0440. 540%u2013544.39. Chang H.H., Lee I.H., Gean P.W., Lee S.Y., Chi M.H., Yang Y.K., Lu R.B., Chen P.S. Treatment response and cognitive impairment in major depression: association with C-reactive protein // Brain Behav Immun. %u2013 2012. %u2013 Vol. 26, no. 1. %u2013 P%u0440. 90%u201395. %u2013 https://doi.org/10.1016/j.bbi.2011.07.23939. Chang H.H., Lee I.H., Gean P.W., Lee S.Y., Chi M.H., Yang Y.K., Lu R.B., Chen P.S. Treatment response and cognitive impairment in major depression: association with C-reactive protein // Brain Behav Immun. %u2013 2012. %u2013 Vol. 26, no. 1. %u2013 P%u0440. 90%u201395. %u2013 https://doi.org/10.1016/j.bbi.2011.07.23940. Krogh J., Benros M.E., J%u00f8rgensen M.B., Vesterager L., Elfving B., Nordentoft M. The association between depressive symptoms, cognitive function, and inflammation in major depression // Brain Behav Immun. %u2013 2014. %u2013 Vol. 35. %u2013 P%u0440. 70%u201376. %u2013 https://doi.org/10.1016/j.bbi.2013.08.01440. Krogh J., Benros M.E., J%u00f8rgensen M.B., Vesterager L., Elfving B., Nordentoft M. The association between depressive symptoms, cognitive function, and inflammation in major depression // Brain Behav Immun. %u2013 2014. %u2013 Vol. 35. %u2013 P%u0440. 70%u201376. %u2013 https://doi.org/10.1016/j.bbi.2013.08.01441. Jin K., Lu J., Yu Z., Shen Z., Li H., Mou T., Xu Y., Huang M. Linking peripheral IL-6, IL-1%u03b2and hypocretin-1 with cognitive impairment from major depression // J Affect Disord. %u2013 2020. %u2013 Vol. 277. %u2013 P%u0440. 204%u2013211. %u2013 https://doi.org/10.1016/j.jad.2020.08.02441. Jin K., Lu J., Yu Z., Shen Z., Li H., Mou T., Xu Y., Huang M. Linking peripheral IL-6, IL-1%u03b2and hypocretin-1 with cognitive impairment from major depression // J Affect Disord. %u2013 2020. %u2013 Vol. 277. %u2013 P%u0440. 204%u2013211. %u2013 https://doi.org/10.1016/j.jad.2020.08.02442. S%u0430%ue088nchez-Carro Y., de la Torre-Luque A., Portella M.J., Leal-Leturia I., Salvat-Pujol N., Massaneda C., de Arriba-Arnau A., Urretavizcaya M., Peret%u043e%ue088 M., Toll A., Mart%u00ednez-Ruiz A., Ferreiros-Martinez R., %u0410%ue098lvarez P., Soria V., L%u043e%ue088pez-Garc%u00eda P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients // Psychoneuroendocrinology. %u2013 2022. %u2013 Vol. 137. %u2013 Art. 105631. %u2013 https://doi.org/10.1016/j.psyneuen.2021.10563142. S%u0430%ue088nchez-Carro Y., de la Torre-Luque A., Portella M.J., Leal-Leturia I., Salvat-Pujol N., Massaneda C., de Arriba-Arnau A., Urretavizcaya M., Peret%u043e%ue088 M., Toll A., Mart%u00ednez-Ruiz A., Ferreiros-Martinez R., %u0410%ue098lvarez P., Soria V., L%u043e%ue088pez-Garc%u00eda P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients // Psychoneuroendocrinology. %u2013 2022. %u2013 Vol. 137. %u2013 Art. 105631. %u2013 https://doi.org/10.1016/j.psyneuen.2021.10563143. Vreijling S.R., Chin Fatt C.R., Williams L.M., Schatzberg A. F., Usherwood T., Nemeroff C.B., Rush A.J., Uher R., Aitchison K.J., K%u00f6hler-Forsberg O., Rietschel M., Trivedi M.H., Jha M.K., Penninx B.W.J.H., Beekman A.T.F., Jansen R., Lamers F. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials // Br J Psychiatry. %u2013 2024. %u2013 Vol. 224, no. 3. %u2013 P%u0440. 89%u201397. %u2013 https://doi.org/10.1192/bjp.2023.14843. Vreijling S.R., Chin Fatt C.R., Williams L.M., Schatzberg A. F., Usherwood T., Nemeroff C.B., Rush A.J., Uher R., Aitchison K.J., K%u00f6hler-Forsberg O., Rietschel M., Trivedi M.H., Jha M.K., Penninx B.W.J.H., Beekman A.T.F., Jansen R., Lamers F. Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials // Br J Psychiatry. %u2013 2024. %u2013 Vol. 224, no. 3. %u2013 P%u0440. 89%u201397. %u2013 https://doi.org/10.1192/bjp.2023.14844. Sampson E., Mills N.T., Hori H., Schwarte K., Hohoff C., Schubert O., Clark S.R., Fourrier C., Baune B.T. Exploratory analysis of the effects of celecoxib on cognitive function in vortioxetine-treated patients with major depressive disorder in the PREDDICT study: A randomized, double-blind, placebo-controlled clinical trial // J Clin Psychiatry. %u2013 2023. %u2013 Vol. 84, no. 6. %u2013 Art. 23m14829. %u2013 https://doi.org/10.4088/JCP.23m1482944. Sampson E., Mills N.T., Hori H., Schwarte K., Hohoff C., Schubert O., Clark S.R., Fourrier C., Baune B.T. Exploratory analysis of the effects of celecoxib on cognitive function in vortioxetine-treated patients with major depressive disorder in the PREDDICT study: A randomized, double-blind, placebo-controlled clinical trial // J Clin Psychiatry. %u2013 2023. %u2013 Vol. 84, no. 6. %u2013 Art. 23m14829. %u2013 https://doi.org/10.4088/JCP.23m1482945. Bai S., Guo W., Feng Y., Deng H., Li G., Nie H., Guo G., Yu H., Ma Y., Wang J., Chen S., Jing J., Yang J., Tang Y., Tang Z. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: A systematic review and meta-analysis of randomised controlled trials // J Neurol Neurosurg Psychiatry. %u2013 2020. %u2013 Vol. 91, no. 1. %u2013 P%u0440. 21%u201332. %u2013 https://doi.org/10.1136/jnnp-2019-32091245. Bai S., Guo W., Feng Y., Deng H., Li G., Nie H., Guo G., Yu H., Ma Y., Wang J., Chen S., Jing J., Yang J., Tang Y., Tang Z. Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: A systematic review and meta-analysis of randomised controlled trials // J Neurol Neurosurg Psychiatry. %u2013 2020. %u2013 Vol. 91, no. 1. %u2013 P%u0440. 21%u201332. %u2013 https://doi.org/10.1136/jnnp-2019-32091246. Varma M., Kaur A., Bhandari R., Kumar A., Kuhad A. Major depressive disorder (MDD): Emerging immune targets at preclinical level // Expert Opin Ther Targets. %u2013 2023. %u2013 Vol. 27, no. 6. %u2013 P%u0440. 479%u2013501. %u2013 https://doi.org/10.1080/14728222.2023.222521646. Varma M., Kaur A., Bhandari R., Kumar A., Kuhad A. Major depressive disorder (MDD): Emerging immune targets at preclinical level // Expert Opin Ther Targets. %u2013 2023. %u2013 Vol. 27, no. 6. %u2013 P%u0440. 479%u2013501. %u2013 https://doi.org/10.1080/14728222.2023.222521647. Appleton K.M., Voyias P.D., Sallis H.M., Dawson S., Ness A.R., Churchill R., Perry R. Omega-3 fatty acids for depression in adults // Cochrane Database Syst Rev. %u2013 2021. %u2013 Vol. 11, no. 11. %u2013 CD004692. %u2013 https://doi.org/10.1002/14651858.CD004692.pub547. Appleton K.M., Voyias P.D., Sallis H.M., Dawson S., Ness A.R., Churchill R., Perry R. Omega-3 fatty acids for depression in adults // Cochrane Database Syst Rev. %u2013 2021. %u2013 Vol. 11, no. 11. %u2013 CD004692. %u2013 https://doi.org/10.1002/14651858.CD004692.pub548. K%u00f6hler-Forsberg O., Otte C., Gold S.M., %u00d8stergaard S.D. Statins in the treatment of depression: Hype or hope? // Pharmacol Ther. %u2013 2020. %u2013 Vol. 215. %u2013 Art. 107625. %u2013 https://doi.org/10.1016/j.pharmthera.2020.10762548. K%u00f6hler-Forsberg O., Otte C., Gold S.M., %u00d8stergaard S.D. Statins in the treatment of depression: Hype or hope? // Pharmacol Ther. %u2013 2020. %u2013 Vol. 215. %u2013 Art. 107625. %u2013 https://doi.org/10.1016/j.pharmthera.2020.10762549. Anmella G., Meehan A., Ashton M., Mohebbi M., Fico G., Ng C.H., Maes M., Berk L., de Prisco M., Singh A.B., Malhi G.S., Berk M., Dodd S., Hidalgo-Mazzei D., Grande I., Pacchiarotti I., Murru A., Vieta E., Dean O.M. Exploring clinical subgroups of participants with major depressive disorder that may benefit from adjunctive minocycline treatment // Clin Psychopharmacol Neurosci. %u2013 2024. %u2013 Vol. 22, no. 1. %u2013 P%u0440. 33%u201344. %u2013 https://doi.org/10.9758/cpn.23.109849. Anmella G., Meehan A., Ashton M., Mohebbi M., Fico G., Ng C.H., Maes M., Berk L., de Prisco M., Singh A.B., Malhi G.S., Berk M., Dodd S., Hidalgo-Mazzei D., Grande I., Pacchiarotti I., Murru A., Vieta E., Dean O.M. Exploring clinical subgroups of participants with major depressive disorder that may benefit from adjunctive minocycline treatment // Clin Psychopharmacol Neurosci. %u2013 2024. %u2013 Vol. 22, no. 1. %u2013 P%u0440. 33%u201344. %u2013 https://doi.org/10.9758/cpn.23.1098